Endolink PharmaS.A.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2021-02-26
Share capital
100 000,00 PLN
Activity description

Endolink Pharma is a company with over 15 years of experience in the medical market, focusing on providing high-quality medical equipment for complex endovascular procedures. They specialize in innovative products for stent and stent graft placement, essential for treating aortic diseases, including aneurysms and dissections. Additionally, they are involved in a urology project addressing urinary incontinence issues in men.

Registered address
Piotrkowska 46/8u, 90-265 Łódź, Poland
Website
endolink.plWebsite active
Email
Email warning
Phone
Social media

Financials

Revenue history

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 5.02kMedianUSD 873.84kAverageUSD 20.03m
Net profit
This companyUSD 121.89MedianUSD 28.21kAverageUSD 815.54k
Operating costs
This companyUSD 4.73kMedianUSD 801.08kAverageUSD 18.78m
Assets
This companyUSD 166.01kMedianUSD 539.29kAverageUSD 10.66m

Bank accounts

Registered as a VAT taxpayer on 2021-04-01. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Authorized Representatives

Piotr Paweł Cioch — President of the Management Board

Manner of representation

If the management board is a one-person management board, the company is represented independently by the sole member of the management board. If the management board is a multi-member management board, the joint action of two members of the management board or of one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Supervisory board

Katarzyna Potargowicz Cioch — Supervisory Board Member
Katarzyna Jolanta Gil — Supervisory Board Member
Ireneusz Mizera — Supervisory Board Member

Beneficial owners

Person
Piotr Paweł Cioch (48)
Katarzyna Jolanta Gil (43)

Competitors

Name
Leenlife PharmaS.A.
Apteczka Pacjentasp. z o.o.
Arjamedicalsp. z o.o.
EDGE Pharmasp. z o.o.
Linkesp. z o.o.
Beyond Medical Aesthetics Polskasp. z o.o.
Filicosp. z o.o.
Polidental Tradesp. z o.o.
Ually Solutionssp. z o.o.

Change history

DateEvent
2024-12-02Address change
2021-02-26Entered in the register

FAQ

Last updated: 2026-07-30